#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15656	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2607	742.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1985	1985	T	1007	T,C,G	1004,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15656	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2607	742.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1719	1719	C	1010	C,T	1009,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26502	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4003	825.0	0	.	n	.	0	T695C	SNP	695	695	T	1257	1257	C	1016	C	1016	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26502	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4003	825.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2200	2200	G	959	G,T	958,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26502	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4003	825.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2533	2533	C	892	C,T,G	889,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26502	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4003	825.0	0	.	n	.	0	C2194T	SNP	2194	2194	C	2756	2756	T	791	T,C	790,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26502	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4003	825.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3159	3159	T	877	T,G	876,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26502	23S	2890	2890	99.83	23S.l15.c4.ctg.1	4003	825.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2607	2607	A	828	A,C	826,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	2168	folP	852	852	100.0	folP.l15.c4.ctg.1	2029	133.2	1	SNP	p	R228S	0	.	.	682	684	CGC	1254	1256	CGC	222;223;224	C,A;G;C,T,A	221,1;223;222,1,1	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5136	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3775	169.3	1	SNP	p	S91F	0	.	.	271	273	TCC	762	764	TCC	179;177;177	T;C;C	179;177;177	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5136	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3775	169.3	1	SNP	p	D95N	0	.	.	283	285	GAC	774	776	GAC	185;186;187	G;A;C	185;186;187	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5136	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3775	169.3	1	SNP	p	D95G	0	.	.	283	285	GAC	774	776	GAC	185;186;187	G;A;C	185;186;187	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1924	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1793	133.8	1	SNP	p	G45D	1	.	.	133	135	GAC	648	650	GAC	244;245;245	G;A,C;C	244;244,1;245	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1058	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c4.ctg.1	1450	90.9	0	.	n	.	0	T10C	SNP	10	10	T	622	622	C	195	C,T	194,1	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1058	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c4.ctg.1	1450	90.9	0	.	n	.	0	A197.	DEL	197	197	A	808	808	A	202	A	201	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5196	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3392	190.9	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1765	1767	GCA	248;248;250	G,A;C;A	247,1;248;250	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5196	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3392	190.9	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2248	2250	ATT	236;236;236	A;T,G;T	236;235,1;236	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5196	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3392	190.9	1	SNP	p	D86N	0	.	.	256	258	GAC	718	720	GAC	227;225;226	G;A,T;C	227;224,1;226	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5196	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3392	190.9	1	SNP	p	S87W	0	.	.	259	261	AGT	721	723	AGT	223;223;225	A,C;G;T	222,1;223;225	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5196	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3392	190.9	1	SNP	p	S87R	0	.	.	259	261	AGT	721	723	AGT	223;223;225	A,C;G;T	222,1;223;225	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5196	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3392	190.9	1	SNP	p	S87I	0	.	.	259	261	AGT	721	723	AGT	223;223;225	A,C;G;T	222,1;223;225	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5196	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3392	190.9	1	SNP	p	S88P	0	.	.	262	264	TCC	724	726	TCC	226;227;224	T;C;C	226;227;224	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4256	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3111	170.3	0	.	p	.	0	G168S	NONSYN	502	504	GGC	1046	1048	AGC	214;214;212	A;G;C	214;214;212	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4256	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3111	170.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1772	1774	GGC	230;229;227	G;G;C	230;229;227	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2903	201.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1496	1498	GCA	265;266;267	G;C;A,C	265;266;266,1	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2903	201.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1499	1501	ATC	266;264;263	A;T;C	266;264;263	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2903	201.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1511	1513	GTG	281;280;276	G;T,A;G	281;279,1;276	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2903	201.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1511	1513	GTG	281;280;276	G;T,A;G	281;279,1;276	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2903	201.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2015	2017	ACC	256;257;258	A,G,C;C;CGG,CG	254,1,1;257;250,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2903	201.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2069	2071	GCG	251;250;251	G;C,G;G,C,A	251;249,1;249,1,1	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2903	201.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2069	2071	GCG	251;250;251	G;C,G;G,C,A	251;249,1;249,1,1	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2903	201.7	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2192	2194	GGT	263;264;261	G,C;G,A;T,C	262,1;262,2;260,1	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2903	201.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2201	2203	GGC	258;257;256	G,T;G,T;C,G	257,1;256,1;255,1	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2903	201.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2219	2221	CCG	258;259;261	C;C,A;G	258;258,1;261	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5648	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3531	199.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1865	1867	CCG	199;199;199	C;C;G	199;199;199	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2240	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2351	118.8	0	.	p	.	0	S22G	NONSYN	64	66	AGC	684	686	GGC	159;159;159	G;G;C	159;159;159	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2240	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2351	118.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	866	866	C	172	C	172	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	96	97.92	porB1a.l6.c4.ctg.1	1570	17.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	260	91.15	porB1a.l6.c4.ctg.2	605	15.5	0	.	p	.	0	S271T	NONSYN	811	813	TCG	87	89	ACT	35;35;35	A;C;T	35;35;35	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	260	91.15	porB1a.l6.c4.ctg.2	605	15.5	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	93	95	GAT	35;35;35	G;A;T	35;35;35	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	260	91.15	porB1a.l6.c4.ctg.2	605	15.5	0	.	p	.	0	D274S	NONSYN	820	822	GAT	96	98	AGT	35;35;35	A;G;T	35;35;35	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	260	91.15	porB1a.l6.c4.ctg.2	605	15.5	0	.	p	.	0	N277H	NONSYN	829	831	AAC	105	107	CAC	35;35;35	C;A;C	35;35;35	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	260	91.15	porB1a.l6.c4.ctg.2	605	15.5	0	.	p	.	0	R307E	NONSYN	919	921	AGA	195	197	GAA	5;5;5	G;A;A	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	260	91.15	porB1a.l6.c4.ctg.2	605	15.5	0	.	p	.	0	T311A	NONSYN	931	933	ACA	207	209	GCA	5;5;5	G;C;A	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	260	91.15	porB1a.l6.c4.ctg.2	605	15.5	0	.	p	.	0	E312D	NONSYN	934	936	GAA	210	212	GAC	5;6;6	G;A;C	5;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	260	91.15	porB1a.l6.c4.ctg.2	605	15.5	0	.	p	.	0	F314I	NONSYN	940	942	TTC	216	218	ATC	6;6;6	A;T;C	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	260	91.15	porB1a.l6.c4.ctg.2	605	15.5	0	.	p	.	0	A316S	NONSYN	946	948	GCG	222	224	TCG	6;6;6	T;C;G	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	260	91.15	porB1a.l6.c4.ctg.2	605	15.5	0	.	p	.	0	V318A	NONSYN	952	954	GTC	228	230	GCC	6;6;6	G;C;C	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	260	91.15	porB1a.l6.c4.ctg.2	605	15.5	0	.	p	.	0	G319S	NONSYN	955	957	GGC	231	233	AGC	6;6;6	A;G;C	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	260	91.15	porB1a.l6.c4.ctg.2	605	15.5	0	.	p	.	0	G320A	NONSYN	958	960	GGT	234	236	GCC	6;6;6	G;C;C	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	516	306	porB1a	984	260	91.15	porB1a.l6.c4.ctg.2	605	15.5	0	.	p	.	0	G322V	NONSYN	964	966	GGT	240	242	GTT	6;6;6	G;T;T	6;6;6	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3146	porB1b	1047	1047	99.81	porB1b.l15.c4.ctg.1	2054	190.7	0	.	p	.	0	G120D	NONSYN	358	360	GGC	873	875	GAC	227;225;225	G,C;A,G,C;C	226,1;221,3,1;225	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3146	porB1b	1047	1047	99.81	porB1b.l15.c4.ctg.1	2054	190.7	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	876	878	AAC	224;229;230	A,G;A;C,A	223,1;229;229,1	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11136	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5370	258.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2226	2228	CAT	295;291;292	C;A,T;T	295;290,1;292	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1674	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1500	138.7	1	SNP	p	V57M	1	.	.	169	171	ATG	812	814	ATG	310;310;313	A,G;T;G	309,1;310;313	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
